Table 1:
Patient characteristics
| Variable | n = 45 |
|---|---|
| Age (years), mean ± SD | 65.9 ± 13.0 |
| Female, n (%) | 29 (64.4) |
| Body surface area (m2), mean ± SD | 1.9 ± 0.3 |
| Hypertension, n (%) | 38 (84.4) |
| Diabetes mellitus, n (%) | 15 (33.3) |
| Hyperlipidaemia, n (%) | 29 (64.4) |
| Creatinine (mg/dl), mean ± SD | 1.06 ± 0.39 |
| Haemodialysis | 0 |
| Liver cirrhosis, n (%) | 2 (4.4) |
| Coronary artery disease, n (%) | 19 (42.2) |
| Cerebrovascular disease, n (%) | 9 (20.0) |
| Atrial fibrillation, n (%) | 20 (44.4) |
| NYHA functional class, n (%) | |
| I | 0 |
| II | 16 (35.5) |
| III | 17 (37.8) |
| IV | 12 (26.7) |
| Previous cardiac surgery, n (%) | 7 (15.6) |
| STS-PROM score (%), mean ± SD | 3.58 ± 3.64 |
| >8%, n (%) | 6 (13.3) |
| EuroSCORE II (%), mean ± SD | 5.37 ± 4.45 |
EuroSCORE II: European System for Cardiac Operative Risk Evaluation II score; NYHA: New York Heart Association; SD: standard deviation; STS-PROM: Society of Thoracic Surgeons predicted risk of mortality.